SQSTM1 and HSPA5 dysregulation has been implicated in neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease (89, 90). The gene discussed is HSPA5; the disease is early-onset autosomal dominant Alzheimer disease.